Clinical Research Studies
Quest carries out Phase I, II, and III studies for pharmaceutical and research companies operating in the following therapeutic areas:
-
HIV (cure, research, & treatment)
-
Hepatitis B (cure & research)
-
NASH/Fatty Liver
-
Triple Negative Breast Cancer
-
Solid Tumor Cancers
Dr. Jacob P. Lalezari, M.D., is the Director of Quest Clinical Research. Since 1989, Dr Lalezari has served as a Principal Investigator for phase I, II, and III clinical studies of new therapies for viral diseases including HIV/AIDS, CMV, HPV, HSV, Hepatitis B &C, Influenza, RSV, and Covid-19. In 1997, he became CEO and Director of Quest Clinical Research.
